SCHEMBL24307490

SCHEMBL24307490

c1ccc2c(c1)oc1cc(-n3c4ccccc4c4ccccc43)ccc1c1ccccc1c1ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.49
MEN1 O00255 6/20 0.47
KMT2A Q03164 6/20 0.47
KDM4E B2RXH2 5/20 0.47
MAPT P10636 5/20 0.47
HPGD P15428 4/20 0.47
ALDH1A1 P00352 3/20 0.47
ATM Q13315 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
PTGER4 P35408 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.41
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
MAOA P21397 4/20 0.40
GAA P10253 3/20 0.38
HSD17B10 Q99714 2/20 0.38
TSHR P16473 1/20 0.38
TP53 P04637 1/20 0.38
GLA P06280 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20232365 1.00 AHR (0.49) AHRMEN1KMT2AKDM4EMAPT
SCHEMBL16442542 0.98 AHR (0.50) AHRMEN1KMT2AKDM4EMAPT
SCHEMBL16409579 0.95 AHR (0.47) AHRMEN1KMT2AKDM4EMAPT
SCHEMBL13932469 0.95 KDM4E (0.52) AHRMEN1KMT2AKDM4EMAPT
SCHEMBL10449463 0.93 AHR (0.46) AHRMEN1KMT2AKDM4EMAPT
SCHEMBL24357013 0.93 AHR (0.46) AHRMEN1KMT2AKDM4EMAPT
SCHEMBL17248342 0.93 AHR (0.46) AHRMEN1KMT2AKDM4EMAPT
SCHEMBL24307494 0.93 KDM4E (0.47) AHRMEN1KMT2AKDM4EMAPT
SCHEMBL24307495 0.93 KDM4E (0.47) AHRMEN1KMT2AKDM4EMAPT
SCHEMBL27044635 0.92 AHR (0.42) AHRMEN1KMT2AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220119418-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2022-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119418-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES BMI1, OXSR1, EED AHR 1880/4885MEN1 1710/4885KMT2A 3025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.